Peng et al. demonstrated that the FXR agonist GW4064 can attenuate hepatic fibrosis and inflammation in MCD diet-fed mice through the FXR-RECK-MMP-9 cascade [29]. This evidence concerns the gene NR1H4 and Hepatic fibrosis.